NCT01804946

Clinical Trial of Clinical Efficiency and Safety of Ergoferon in Treatment of Influenza

Multicentre Open Label Comparative Parallel-group Randomized Clinical Trial of Clinical Efficiency and Safety of Ergoferon in Treatment of Influenza

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 161 (actual)
• Sponsor: Materia Medica Holding · Industry
• Sex: All
• Age: 18 Years – 60 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is: * to assess clinical efficiency of Ergoferon for treatment of influenza * to assess safety of Ergoferon for treatment of influenza * to compare efficiency of Ergoferon and Tamiflu for treatment of influenza

Conditions

• Influenza

Interventions

Type	Name	Description
DRUG	Ergoferon	Safety and Efficiency of Ergoferon in treatment of Influenza
DRUG	Oseltamivir	Safety and Efficiency in treatment of Influenza

Timeline

• Start date: 2011-02-01
• Primary completion: 2014-04-01
• Completion: 2014-10-01
• First posted: 2013-03-05
• Last updated: 2015-06-23
• Results posted: 2015-06-23

Locations

8 sites across 1 country: Russia